• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.

作者信息

Schaad U B, Stoupis C, Wedgwood J, Tschaeppeler H, Vock P

机构信息

Department of Pediatrics, University of Berne, Switzerland.

出版信息

Pediatr Infect Dis J. 1991 Oct;10(10):723-9.

PMID:1945573
Abstract

Because of arthropathic toxicity observed in growing animals the quinolone antibiotics are not recommended for use in children. Recently, magnetic resonance imaging performed in juvenile animals was found to predict ciprofloxacin-induced cartilage damage at the knee joint. We conducted clinical, laboratory, radiologic and magnetic resonance imaging investigations in 13 prepubertal (age range, 6 to 13 years) and 5 postpubertal patients (age range, 14 to 24 years) with cystic fibrosis at the start and the end of a 3-month course of ciprofloxacin (30 mg/kg of body weight/day, administered orally in two equal doses) and at follow-up 4 to 6 months later. Our comprehensive monitoring gave no evidence for arthropathogenicity. Detailed physical skeletal function tests, height velocity values, laboratory studies of bone metabolism and conventional radiographs of both knees revealed no abnormalities. Moreover the serial magnetic resonance images of the left knee demonstrated lack of joint effusion, intact two-layer appearance of the cartilage and unaffected thickness of the articular cartilage measured at five anatomically different points. Our results together with the published data on quinolone use in pediatrics suggest that ciprofloxacin does not cause arthropathy in humans.

摘要

相似文献

1
Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.
Pediatr Infect Dis J. 1991 Oct;10(10):723-9.
2
Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey.接受喹诺酮类药物治疗的儿童的磁共振成像:无喹诺酮类药物诱发关节病的证据。一项多中心调查。
Chemotherapy. 1994 May-Jun;40(3):209-14. doi: 10.1159/000239194.
3
Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning.口服环丙沙星治疗小儿囊性纤维化假单胞菌感染加重:使用磁共振成像扫描进行临床疗效和安全性评估
J Int Med Res. 1998 Dec;26(6):304-12. doi: 10.1177/030006059802600604.
4
Arthropathy in a patient with cystic fibrosis taking ciprofloxacin.一名正在服用环丙沙星的囊性纤维化患者出现关节病。
Br Med J (Clin Res Ed). 1987 Sep 19;295(6600):699. doi: 10.1136/bmj.295.6600.699.
5
Cystic fibrosis and drug-induced arthropathy.囊性纤维化与药物性关节病。
Br J Rheumatol. 1989 Apr;28(2):179-80. doi: 10.1093/rheumatology/28.2.179-a.
6
[Comparative morphological analysis of the articular cartilage, epiphyseal plate, spongy bone, and synovial membrane of the knee joint in children treated and not treated with ciprofloxacin].[环丙沙星治疗与未治疗儿童膝关节的关节软骨、骨骺板、松质骨和滑膜的比较形态学分析]
Antibiot Khimioter. 2000;45(11):9-13.
7
Use of the new quinolones in pediatrics.
Isr J Med Sci. 1994 May-Jun;30(5-6):463-8.
8
[Use of quinolones in the treatment of Pseudomonas aeruginosa infections in children with cystic fibrosis].喹诺酮类药物在治疗囊性纤维化儿童铜绿假单胞菌感染中的应用
Pediatr Med Chir. 1995 Jan-Feb;17(1):53-5.
9
[Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].环丙沙星、氧氟沙星和培氟沙星治疗囊性纤维化患儿呼吸道感染的疗效与安全性比较
Antibiot Khimioter. 2001;46(3):16-20.
10
Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient.一名成年囊性纤维化患者继发于环丙沙星的关节病
Ann Pharmacother. 1993 Mar;27(3):302-3. doi: 10.1177/106002809302700308.

引用本文的文献

1
Arthritis in Cystic Fibrosis-Comparison of a Single-Center Cohort and Published Case Reports/Series and a Review of the Literature.囊性纤维化中的关节炎——单中心队列与已发表病例报告/系列的比较及文献综述
APMIS. 2025 Aug;133(8):e70058. doi: 10.1111/apm.70058.
2
Population pharmacokinetics of intravenous and oral ciprofloxacin in children to optimize dosing regimens.儿童静脉和口服环丙沙星的群体药代动力学研究,以优化给药方案。
Eur J Clin Pharmacol. 2021 Nov;77(11):1687-1695. doi: 10.1007/s00228-021-03174-1. Epub 2021 Jun 23.
3
Options for treating resistant Shigella species infections in children.
儿童耐药志贺菌属感染的治疗选择。
J Pediatr Pharmacol Ther. 2008 Jan;13(1):29-43. doi: 10.5863/1551-6776-13.1.29.
4
Ciprofloxacin safety in paediatrics: a systematic review.环丙沙星在儿科中的安全性:系统评价。
Arch Dis Child. 2011 Sep;96(9):874-80. doi: 10.1136/adc.2010.208843. Epub 2011 Jul 23.
5
Travellers' diarrhea in children.儿童旅行者腹泻
Paediatr Child Health. 2003 Feb;8(2):99-103. doi: 10.1093/pch/8.2.99.
6
Staphylococcal skin infections in children: rational drug therapy recommendations.儿童葡萄球菌皮肤感染:合理用药治疗建议
Paediatr Drugs. 2005;7(2):77-102. doi: 10.2165/00148581-200507020-00002.
7
Fluoroquinolones in paediatrics.儿科中的氟喹诺酮类药物。
Paediatr Drugs. 2001;3(5):365-77. doi: 10.2165/00128072-200103050-00005.
8
Comparative tolerability of the newer fluoroquinolone antibacterials.新型氟喹诺酮类抗菌药物的耐受性比较
Drug Saf. 1999 Nov;21(5):407-21. doi: 10.2165/00002018-199921050-00005.
9
Quinolone use in the developing world: state of the art.喹诺酮类药物在发展中世界的应用:最新进展
Drugs. 1999;58 Suppl 2:55-9. doi: 10.2165/00003495-199958002-00011.
10
Fluoroquinolones in paediatrics.儿科中的氟喹诺酮类药物。
Drugs. 1999;58 Suppl 2:43-8. doi: 10.2165/00003495-199958002-00008.